# FIGS, Inc.: financial statements, quarterly

FIGS · NYSE · CIK 1846576 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/figs.md) · [Financials](/companies/figs/financials.md) · [Filings](/companies/figs/filings.md) · [Insiders](/companies/figs/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/figs/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [142](/filings/0001628280-24-046367.md) | [145 d](/filings/0001628280-26-012333.md) | [119](/filings/0001628280-25-023887.md) | [144](/filings/0001628280-25-038989.md) | [140](/filings/0001628280-25-050211.md) | [152 d](/filings/0001628280-26-012333.md) | [125](/filings/0001628280-26-032216.md) | [153](/filings/0001628280-26-054342.md) | [152](/filings/0001628280-25-050211.md) | [202 d](/filings/0001628280-26-012333.md) | [160](/filings/0001628280-26-032216.md) | [197](/filings/0001628280-26-054342.md) |
| Cost of revenue | $m | [45.0](/filings/0001628280-24-046367.md) | [47.1 d](/filings/0001628280-26-012333.md) | [37.2](/filings/0001628280-25-023887.md) | [47.0](/filings/0001628280-25-038989.md) | [46.2](/filings/0001628280-25-050211.md) | [49.6 d](/filings/0001628280-26-012333.md) | [40.4](/filings/0001628280-26-032216.md) | [50.4](/filings/0001628280-26-054342.md) | [45.6](/filings/0001628280-25-050211.md) | [74.8 d](/filings/0001628280-26-012333.md) | [51.6](/filings/0001628280-26-032216.md) | [48.8](/filings/0001628280-26-054342.md) |
| Gross profit | $m | [97.4](/filings/0001628280-24-046367.md) | [97.9 d](/filings/0001628280-26-012333.md) | [82.1](/filings/0001628280-25-023887.md) | [97.3](/filings/0001628280-25-038989.md) | [94.0](/filings/0001628280-25-050211.md) | [102 d](/filings/0001628280-26-012333.md) | [84.5](/filings/0001628280-26-032216.md) | [102](/filings/0001628280-26-054342.md) | [106](/filings/0001628280-25-050211.md) | [127 d](/filings/0001628280-26-012333.md) | [108](/filings/0001628280-26-032216.md) | [148](/filings/0001628280-26-054342.md) |
| Operating income | $m | [10.0](/filings/0001628280-24-046367.md) | [14.2 d](/filings/0001628280-26-012333.md) | [0.4](/filings/0001628280-25-023887.md) | [1.6](/filings/0001628280-25-038989.md) | [(8.6)](/filings/0001628280-25-050211.md) | [8.9 d](/filings/0001628280-26-012333.md) | [(0.2)](/filings/0001628280-26-032216.md) | [9.9](/filings/0001628280-26-054342.md) | [9.6](/filings/0001628280-25-050211.md) | [18.8 d](/filings/0001628280-26-012333.md) | [4.5](/filings/0001628280-26-032216.md) | [35.3](/filings/0001628280-26-054342.md) |
| Income tax | $m | [5.7](/filings/0001628280-24-046367.md) | [6.5 d](/filings/0001628280-26-012333.md) | [1.8](/filings/0001628280-25-023887.md) | [3.3](/filings/0001628280-25-038989.md) | [(4.0)](/filings/0001628280-25-050211.md) | [10.5 d](/filings/0001628280-26-012333.md) | [2.0](/filings/0001628280-26-032216.md) | [4.9](/filings/0001628280-26-054342.md) | [3.2](/filings/0001628280-25-050211.md) | [2.8 d](/filings/0001628280-26-012333.md) | [0.2](/filings/0001628280-26-032216.md) | [8.5](/filings/0001628280-26-054342.md) |
| Net income | $m | [6.1](/filings/0001628280-24-046367.md) | [10.0 d](/filings/0001628280-26-012333.md) | [1.4](/filings/0001628280-25-050211.md) | [1.1](/filings/0001628280-25-050211.md) | [(1.7)](/filings/0001628280-25-050211.md) | [1.9 d](/filings/0001628280-26-012333.md) | [(0.1)](/filings/0001628280-26-054342.md) | [7.1](/filings/0001628280-26-054342.md) | [8.7](/filings/0001628280-25-050211.md) | [18.5 d](/filings/0001628280-26-012333.md) | [6.3](/filings/0001628280-26-054342.md) | [28.4](/filings/0001628280-26-054342.md) |
| Diluted EPS | $ per share | [0.03](/filings/0001628280-24-046367.md) | not reported | [0.01](/filings/0001628280-25-023887.md) | [0.01](/filings/0001628280-25-038989.md) | [(0.01)](/filings/0001628280-25-050211.md) | not reported | [0.00](/filings/0001628280-26-032216.md) | [0.04](/filings/0001628280-26-054342.md) | [0.05](/filings/0001628280-25-050211.md) | not reported | [0.03](/filings/0001628280-26-032216.md) | [0.15](/filings/0001628280-26-054342.md) |
| Basic EPS | $ per share | [0.04](/filings/0001628280-24-046367.md) | not reported | [0.01](/filings/0001628280-25-023887.md) | [0.01](/filings/0001628280-25-038989.md) | [(0.01)](/filings/0001628280-25-050211.md) | not reported | [0.00](/filings/0001628280-26-032216.md) | [0.04](/filings/0001628280-26-054342.md) | [0.05](/filings/0001628280-25-050211.md) | not reported | [0.04](/filings/0001628280-26-032216.md) | [0.17](/filings/0001628280-26-054342.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [183](/filings/0001628280-23-036408.md) | [144](/filings/0001628280-25-008688.md) | [155](/filings/0001628280-24-022258.md) | [132](/filings/0001628280-24-036155.md) | [124](/filings/0001628280-24-046367.md) | [85.6](/filings/0001628280-26-012333.md) | [90.0](/filings/0001628280-25-023887.md) | [50.8](/filings/0001628280-25-038989.md) | [46.5](/filings/0001628280-25-050211.md) | [82.0](/filings/0001628280-26-054342.md) | [74.3](/filings/0001628280-26-032216.md) | [109](/filings/0001628280-26-054342.md) |
| Current assets | $m | [395](/filings/0001628280-23-036408.md) | [386](/filings/0001628280-25-008688.md) | [406](/filings/0001628280-24-022258.md) | [417](/filings/0001628280-24-036155.md) | [434](/filings/0001628280-24-046367.md) | [383](/filings/0001628280-26-012333.md) | [400](/filings/0001628280-25-023887.md) | [394](/filings/0001628280-25-038989.md) | [418](/filings/0001628280-25-050211.md) | [447](/filings/0001628280-26-054342.md) | [432](/filings/0001628280-26-032216.md) | [453](/filings/0001628280-26-054342.md) |
| Total assets | $m | [442](/filings/0001628280-23-036408.md) | [473](/filings/0001628280-25-008688.md) | [511](/filings/0001628280-24-022258.md) | [526](/filings/0001628280-24-036155.md) | [542](/filings/0001628280-24-046367.md) | [510](/filings/0001628280-26-012333.md) | [522](/filings/0001628280-25-023887.md) | [517](/filings/0001628280-25-038989.md) | [545](/filings/0001628280-25-050211.md) | [580](/filings/0001628280-26-054342.md) | [563](/filings/0001628280-26-032216.md) | [583](/filings/0001628280-26-054342.md) |
| Current liabilities | $m | [70.2](/filings/0001628280-23-036408.md) | [57.3](/filings/0001628280-25-008688.md) | [71.8](/filings/0001628280-24-022258.md) | [76.6](/filings/0001628280-24-036155.md) | [94.7](/filings/0001628280-24-046367.md) | [90.1](/filings/0001628280-26-012333.md) | [101](/filings/0001628280-25-023887.md) | [78.4](/filings/0001628280-25-038989.md) | [86.7](/filings/0001628280-25-050211.md) | [90.5](/filings/0001628280-26-054342.md) | [80.2](/filings/0001628280-26-032216.md) | [91.4](/filings/0001628280-26-054342.md) |
| Total liabilities | $m | [86.6](/filings/0001628280-23-036408.md) | [96.4](/filings/0001628280-25-008688.md) | [121](/filings/0001628280-24-022258.md) | [124](/filings/0001628280-24-036155.md) | [139](/filings/0001628280-24-046367.md) | [133](/filings/0001628280-26-012333.md) | [141](/filings/0001628280-25-023887.md) | [121](/filings/0001628280-25-038989.md) | [131](/filings/0001628280-25-050211.md) | [143](/filings/0001628280-26-054342.md) | [133](/filings/0001628280-26-032216.md) | [140](/filings/0001628280-26-054342.md) |
| Shareholders' equity | $m | [355](/filings/0001628280-24-046367.md) | [377](/filings/0001628280-26-012333.md) | [390](/filings/0001628280-25-050211.md) | [402](/filings/0001628280-25-050211.md) | [404](/filings/0001628280-25-050211.md) | [377](/filings/0001628280-26-054342.md) | [382](/filings/0001628280-26-054342.md) | [397](/filings/0001628280-26-054342.md) | [413](/filings/0001628280-25-050211.md) | [437](/filings/0001628280-26-054342.md) | [431](/filings/0001628280-26-054342.md) | [442](/filings/0001628280-26-054342.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [54.1 d](/filings/0001628280-24-046367.md) | [20.3 d](/filings/0001628280-26-012333.md) | [11.6](/filings/0001628280-25-023887.md) | [16.5 d](/filings/0001628280-25-038989.md) | [22.6 d](/filings/0001628280-25-050211.md) | [30.4 d](/filings/0001628280-26-012333.md) | [9.2](/filings/0001628280-26-032216.md) | [(12.4) d](/filings/0001628280-26-054342.md) | [3.4 d](/filings/0001628280-25-050211.md) | [60.9 d](/filings/0001628280-26-012333.md) | [(3.2)](/filings/0001628280-26-032216.md) | [46.9 d](/filings/0001628280-26-054342.md) |
| Capital expenditure | $m | [8.1 d](/filings/0001628280-24-046367.md) | [6.6 d](/filings/0001628280-26-012333.md) | [0.5](/filings/0001628280-25-023887.md) | [9.0 d](/filings/0001628280-25-038989.md) | [4.2 d](/filings/0001628280-25-050211.md) | [3.4 d](/filings/0001628280-26-012333.md) | [1.3](/filings/0001628280-26-032216.md) | [1.1 d](/filings/0001628280-26-054342.md) | [2.9 d](/filings/0001628280-25-050211.md) | [2.9 d](/filings/0001628280-26-012333.md) | [2.4](/filings/0001628280-26-032216.md) | [2.6 d](/filings/0001628280-26-054342.md) |
| Share repurchases | $m | not reported | [0.0 d](/filings/0001628280-26-012333.md) | [0.0](/filings/0001628280-25-023887.md) | [0.0 d](/filings/0001628280-25-038989.md) | [7.3 d](/filings/0001628280-25-050211.md) | [38.2 d](/filings/0001628280-26-012333.md) | [2.7](/filings/0001628280-26-032216.md) | [0.0 d](/filings/0001628280-26-054342.md) | [0.0 d](/filings/0001628280-25-050211.md) | [0.0 d](/filings/0001628280-26-012333.md) | [8.8](/filings/0001628280-26-032216.md) | [24.0 d](/filings/0001628280-26-054342.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [187](/filings/0001628280-23-036408.md) | [183](/filings/0001628280-24-022258.md) | [183](/filings/0001628280-24-036155.md) | [181](/filings/0001628280-24-046367.md) | [181](/filings/0001628280-25-023887.md) | [180](/filings/0001628280-25-038989.md) | [170](/filings/0001628280-25-050211.md) | [162](/filings/0001628280-26-032216.md) | [173](/filings/0001628280-26-054342.md) | [181](/filings/0001628280-25-050211.md) | [196](/filings/0001628280-26-032216.md) | [195](/filings/0001628280-26-054342.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.